Would you recommend the following article to a politician, an athlete, a business executive, or a scientist?

Analysts expect drop in stent sales Boston Scientific Corp. may forecast a drop in third-quarter sales of its Taxus heart stent after three recalls cut demand for the device, the company's top-selling product.
